TY  - GEN
AU  - Gobin,Bérengère
AU  - Huin,Marc Baud'
AU  - Lamoureux,François
AU  - Ory,Benjamin
AU  - Charrier,Céline
AU  - Lanel,Rachel
AU  - Battaglia,Séverine
AU  - Redini,Françoise
AU  - Lezot,Frédéric
AU  - Blanchard,Frédéric
AU  - Heymann,Dominique
TI  - BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma
SN  - 1097-0215
PY  - 2015///0214
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Drug Synergism
KW  - Female
KW  - Humans
KW  - Inhibitory Concentration 50
KW  - Male
KW  - Mice, Inbred C57BL
KW  - Mice, Nude
KW  - Osteoblasts
KW  - drug effects
KW  - Osteoclasts
KW  - Osteosarcoma
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Thiazoles
KW  - administration & dosage
KW  - Tumor Burden
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ijc.29040
ER  -